Familial Hyperkalemic Hypertension.

Area of Science:

• Nephrology
• Genetics
• Molecular Biology

Background:

• Familial Hyperkalemic Hypertension (FHHt) is a rare genetic disorder.
• Mutations in CUL3, KLHL3, WNK1, and WNK4 genes cause FHHt.
• These mutations lead to hyperactivation of NCC in the kidney.

Purpose of the Study:

• To outline the discovery of molecular pathways regulating NCC and vascular tone.
• To explain how FHHt mutations disrupt these pathways.
• To explore mechanisms of disease severity variability and potential extra-renal effects.

Main Methods:

• In vitro studies
• In vivo studies

Main Results:

• CUL3 and KLHL3 form a complex that degrades WNK kinases.
• Mutations disrupt this complex, leading to NCC hyperactivation.
• CUL3 mutations also affect vasculature, contributing to hypertension.

Conclusions:

• FHHt molecular pathways involve CUL3-KLHL3 ubiquitin ligase complex and WNK kinases.
• Mutations disrupt NCC regulation and vascular tone, causing hypertension and hyperkalemia.
• Variability in FHHt severity may relate to differential kidney and vascular effects.